背景:减少危害是解决可注射药物使用的多方面挑战的关键方法。本文介绍了在可注射药物使用背景下减少危害研究的现有文献的分析和绘图。通过回顾一套全面的学术文章,这项研究确定了研究热点,知识差距,以及该领域的未来方向。这些发现为研究人员提供了有价值的见解,政策制定者,和从业人员来指导未来的研究工作,并为基于证据的减少伤害干预措施提供信息。
方法:研究数据来自Scopus数据库,使用与减少伤害和注射药物使用相关的关键词和短语。采用验证方法验证了搜索策略的准确性和全面性。数据分析涉及确定生长模式,关键贡献者,映射频繁项,确定研究热点,并确定新兴的研究方向。
结果:共发现971篇文章,从2015年到2022年有显著增长。《国际药物政策杂志》(n=172,17.7%)和《减少危害杂志》(n=104,10.7%)是最多产的期刊,美国(n=558,57.5%)的出版物数量最多。约翰霍普金斯大学(n=80,8.5%)是最多产的机构。频繁的作者关键词映射揭示了主要关键词,包括减少伤害,艾滋病毒,丙型肝炎,和阿片类药物过量。被高度引用的文章涵盖了广泛的时间跨度,并专注于纳洛酮分布等主题,艾滋病毒和丙型肝炎的传播,虽然最近的文章集中于新出现的问题,如COVID-19大流行的影响,芬太尼相关的问题,柱头减少,以及针头和注射器程序。两组文章都共同关注减少伤害战略,但是最近的出版物强调了该领域当前的挑战和发展。
结论:这项研究提供了关于减少注射药物使用危害的研究前景的见解。研究集中在高收入国家,强调需要在低收入和中等收入国家进行更多的研究。最近的出版物集中于新出现的挑战,如COVID-19和芬太尼。研究差距凸显了在不同人群中进行研究的必要性,社会决定因素,项目评估,和实施战略,以加强减少伤害的干预措施。
Harm reduction is a crucial approach in addressing the multifaceted challenges of injectable drug use. This paper presents an analysis and mapping of the existing literature on harm reduction research in the context of injectable drug use. By reviewing a comprehensive set of scholarly articles, this study identifies research hotspots, knowledge gaps, and future directions in the field. The findings provide valuable insights for researchers, policymakers, and practitioners to guide future research efforts and inform evidence-based harm reduction interventions.
Data for the study was obtained from the Scopus database, using keywords and phrases related to harm reduction and injectable drug use. Validation methods were employed to verify the accuracy and comprehensiveness of the search strategy. Data analysis involved identifying growth patterns, key contributors, mapping frequent terms, identifying research hotspots, and identifying emerging research directions.
A total of 971 articles were found, with a notable increase from 2015 to 2022. The International Journal of Drug Policy (n = 172, 17.7%) and the Harm Reduction Journal (n = 104, 10.7%) were the most prolific journals, and the United States (n = 558, 57.5%) had the highest number of publications. The Johns Hopkins University (n = 80, 8.5%) was the most prolific institution. Mapping of frequent author keywords revealed the main keywords, including harm reduction, HIV, hepatitis C, and opioid overdose. The highly cited articles cover a broad time span and focus on topics like naloxone distribution, HIV and hepatitis C transmission, while recent articles concentrate on emerging issues such as the impact of the COVID-19 pandemic, fentanyl-related concerns, stigma reduction, and needle and syringe programs. Both sets of articles share a common focus on harm reduction strategies, but recent publications highlight current challenges and developments in the field.
This study provides insights into research landscape on harm reduction in injectable drug use. Research is concentrated in high-income countries, emphasizing the need for more research in low- and middle-income countries. Recent publications focus on emerging challenges like COVID-19 and fentanyl. Research gaps highlight the need for studies in diverse populations, social determinants, program evaluation, and implementation strategies to enhance harm reduction interventions.